Antengene Announces IND Approval in China for the Phase…
The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with…
The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with…
Exploring how India’s 1.6 lakh startups are redefining global innovation,…